Harnessing and modulating inflammation in strategies for bone regeneration.
暂无分享,去创建一个
Antonios G Mikos | F Kurtis Kasper | A. Mikos | F. Kasper | Paschalia M Mountziaris | Patrick P Spicer | P. Spicer | P. Mountziaris
[1] Hiroshi Takayanagi,et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ , 2000, Nature.
[2] Dongan Wang,et al. In vivo and in vitro osteogenesis of stem cells induced by controlled release of drugs from microspherical scaffolds , 2010 .
[3] M. Feldmann,et al. TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells , 2011, Proceedings of the National Academy of Sciences.
[4] D. Hu,et al. Action of IL‐1β during fracture healing , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[5] T. Sculco,et al. Prophylaxis of Heterotopic Ossification of the Hip: Systematic Review and Meta‐Analysis , 2009 .
[6] Kozo Nakamura,et al. Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders. , 2008, Arthritis and rheumatism.
[7] S. Mckercher,et al. Wound Healing in the PU.1 Null Mouse—Tissue Repair Is Not Dependent on Inflammatory Cells , 2003, Current Biology.
[8] L. Nordsletten,et al. Parecoxib and Indomethacin Delay Early Fracture Healing: A Study in Rats , 2009, Clinical orthopaedics and related research.
[9] Per Aspenberg,et al. Drugs and fracture repair , 2005, Acta orthopaedica.
[10] Xin-Fu Zhou,et al. Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative , 2009, Nature Clinical Practice Rheumatology.
[11] R. Zhao,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.
[12] A. Kaneko,et al. Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis , 2010, Clinical Rheumatology.
[13] A. Reznick,et al. Exposure to pro-inflammatory cytokines upregulates MMP-9 synthesis by mesenchymal stem cells-derived osteoprogenitors , 2008, Histochemistry and Cell Biology.
[14] Meijing Wang,et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. , 2008, American journal of physiology. Cell physiology.
[15] D. Magne,et al. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. , 2009, Life sciences.
[16] C. Colnot,et al. Trauma-Induced Inflammation and Fracture Healing , 2010, Journal of orthopaedic trauma.
[17] Nimrod Rozen,et al. Fracture repair: modulation of fracture-callus and mechanical properties by sequential application of IL-6 following PTH 1-34 or PTH 28-48. , 2007, Bone.
[18] D. Graves,et al. Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .
[19] C. Bourgeault,et al. OP-1 Augments Glucocorticoid-inhibited Fracture Healing in a Rat Fracture Model , 2009, Clinical orthopaedics and related research.
[20] A. M. Simon,et al. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture-healing. , 2007, The Journal of bone and joint surgery. American volume.
[21] E. Schwarz,et al. Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins* , 2008, Journal of Biological Chemistry.
[22] E. Krall,et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. , 2007, The Journal of bone and joint surgery. American volume.
[23] H. Takayanagi. Osteoimmunology and the effects of the immune system on bone , 2009, Nature Reviews Rheumatology.
[24] Nona T Colburn,et al. A role for gamma/delta T cells in a mouse model of fracture healing. , 2009, Arthritis and rheumatism.
[25] Antonios G Mikos,et al. Modulation of the inflammatory response for enhanced bone tissue regeneration. , 2008, Tissue engineering. Part B, Reviews.
[26] M. Boers,et al. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice , 2010, Annals of the rheumatic diseases.
[27] S. Doty,et al. Thrombin peptide (TP508) promotes fracture repair by up‐regulating inflammatory mediators, early growth factors, and increasing angiogenesis , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[28] L Dunn,et al. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery , 2000, Acta orthopaedica Scandinavica.
[29] S A Goldstein,et al. Osteoporosis induced in mice by overproduction of interleukin 4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] F. Kaplan,et al. Fibrodysplasia ossificans progressiva , 2008, Best practice & research. Clinical rheumatology.
[31] R. Quigg,et al. TP508 accelerates fracture repair by promoting cell growth over cell death. , 2007, Biochemical and biophysical research communications.
[32] Thomas A Einhorn,et al. High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. , 2009, The American journal of pathology.
[33] A. M. Simon,et al. Cyclo‐Oxygenase 2 Function Is Essential for Bone Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] E. Schwarz,et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.
[35] D. Carney,et al. Could rusalatide acetate be the future drug of choice for diabetic foot ulcers and fracture repair? , 2008, Expert opinion on pharmacotherapy.
[36] R. Guldberg,et al. Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. , 2009, The American journal of pathology.
[37] R. Guldberg,et al. COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. , 2008, Bone.
[38] Jiro Takito,et al. Inhibition of STAT1 accelerates bone fracture healing , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[39] D. Macdonald,et al. Nonunion of the femoral diaphysis , 2000 .
[40] J. Kuiper,et al. The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study , 2009, Journal of orthopaedic surgery and research.
[41] Georg N Duda,et al. Insight into the molecular pathophysiology of delayed bone healing in a sheep model. , 2010, Tissue engineering. Part A.
[42] M. Bostrom,et al. Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model , 2000, Acta orthopaedica Scandinavica.
[43] J. Jacobs,et al. Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis , 2010, Nature Reviews Rheumatology.
[44] Cory Berkland,et al. Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects. , 2010, Biomaterials.
[45] A. Caplan. Why are MSCs therapeutic? New data: new insight , 2009, The Journal of pathology.
[46] J. David,et al. The multiple faces of autoimmune-mediated bone loss , 2010, Nature Reviews Endocrinology.
[47] D. Hu,et al. Rejuvenation of the inflammatory system stimulates fracture repair in aged mice , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[48] Antonios G Mikos,et al. Dose effect of tumor necrosis factor-alpha on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds. , 2010, Biomaterials.
[49] E. Gómez-Barrena,et al. Role of the N- and C-terminal fragments of parathyroid-hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment. , 2010, Tissue engineering. Part A.
[50] Liping Tang,et al. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. , 2010, Biomaterials.
[51] C. Bäckesjö,et al. IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. , 2008, Cytokine.
[52] R. Pereira,et al. Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts “in vitro” , 2008, Clinical Rheumatology.
[53] C. Krettek,et al. Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. , 2000 .
[54] T A Einhorn,et al. Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[55] N. Pleshko Camacho,et al. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. , 2007, Bone.
[56] S. Vukicevic,et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Hamilton,et al. Proinflammatory cytokines inhibit osteogenic differentiation from stem cells: implications for bone repair during inflammation. , 2009, Osteoarthritis and cartilage.
[58] Y. Kapila,et al. TNF-α Promotes an Odontoblastic Phenotype in Dental Pulp Cells , 2009, Journal of dental research.
[59] D. Solomon,et al. Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fractures. , 2005, Arthritis and rheumatism.
[60] S. Goodman,et al. The Effects of Medications on Bone , 2007, The Journal of the American Academy of Orthopaedic Surgeons.
[61] R. Landewé,et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA , 2010, Annals of the rheumatic diseases.
[62] A R Pettit,et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. , 2001, The American journal of pathology.
[63] C. Ohlsson,et al. Bone formation in interleukin‐4 and interleukin‐13 depleted mice , 2008, Acta orthopaedica.
[64] G. Duda,et al. Cellular composition of the initial fracture hematoma compared to a muscle hematoma: A study in sheep , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[65] K. Miyazono,et al. Cathepsin K-Dependent Toll-Like Receptor 9 Signaling Revealed in Experimental Arthritis , 2008, Science.
[66] T. Notomi,et al. Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice. , 2011, Arthritis and rheumatism.
[67] A. Wetterwald,et al. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro. , 2006, Bone.
[68] J. Anglen,et al. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. , 2003, The Journal of bone and joint surgery. British volume.
[69] J. Jansen,et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. , 2005, Journal of biomedical materials research. Part A.
[70] Subburaman Mohan,et al. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. , 2006, Bone.
[71] D. Docheva,et al. IKK-2 is required for TNF-α-induced invasion and proliferation of human mesenchymal stem cells , 2008, Journal of Molecular Medicine.
[72] J. Parvizi,et al. Nonsteroidal anti-inflammatory drugs in orthopaedics. , 2009, The Journal of bone and joint surgery. American volume.
[73] M. Kotoula,et al. Parecoxib has non-significant long-term effects on bone healing in rats when administered for a short period after fracture , 2008, Archives of Orthopaedic and Trauma Surgery.
[74] T. Einhorn,et al. Impaired Intramembranous Bone Formation during Bone Repair in the Absence of Tumor Necrosis Factor-Alpha Signaling , 2001, Cells Tissues Organs.
[75] J. Cottrell,et al. Pharmacological inhibition of 5-lipoxygenase accelerates and enhances fracture-healing. , 2009, The Journal of bone and joint surgery. American volume.
[76] G. Stein,et al. Enhanced fracture repair by leukotriene antagonism is characterized by increased chondrocyte proliferation and early bone formation: A novel role of the cysteinyl LT‐1 receptor , 2009, Journal of cellular physiology.
[77] Y. Toyama,et al. Fra‐1/AP‐1 Impairs Inflammatory Responses and Chondrogenesis in Fracture Healing , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[78] J. Kinney,et al. Repair of rabbit segmental defects with the thrombin peptide, TP508 , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[79] Thomas A Einhorn,et al. Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[80] Kristi S Anseth,et al. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha. , 2009, Biomaterials.
[81] Y. Iwakura,et al. IL-1 plays an important role in the bone metabolism under physiological conditions. , 2010, International immunology.
[82] M. Dougados,et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. , 2007, Clinical and experimental rheumatology.
[83] J. Cottrell,et al. Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone Healing , 2010, Pharmaceuticals.
[84] Toshitaka Nakamura,et al. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. , 2004, Bone.
[85] A. Wymenga,et al. Risk Factors for Surgical Site Infections and Other Complications in Elective Surgery in Patients with Rheumatoid Arthritis with Special Attention for Anti-Tumor Necrosis Factor: A Large Retrospective Study , 2008 .
[86] Hong Zhou,et al. Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing , 2010, Steroids.
[87] A. Ivković,et al. Autologous bone grafting on steroids: preliminary clinical results. A novel treatment for nonunions and segmental bone defects , 2011, International Orthopaedics.
[88] G. Stein,et al. Arachidonic Acid, Eicosanoids, and Fracture Repair , 2010, Journal of orthopaedic trauma.
[89] E. Schwarz,et al. EP1−/− Mice Have Enhanced Osteoblast Differentiation and Accelerated Fracture Repair , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[90] K. Ikari,et al. Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications? , 2010, Rheumatology.
[91] G. Duda,et al. Fracture healing is accelerated in the absence of the adaptive immune system , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[92] R. Reis,et al. Ex vivo culturing of stromal cells with dexamethasone-loaded carboxymethylchitosan/poly(amidoamine) dendrimer nanoparticles promotes ectopic bone formation. , 2010, Bone.
[93] G. Lyritis,et al. Effect of cortisone and an anabolic steroid upon plasma hydroxyproline during fracture healing in rabbits. , 1975, Acta orthopaedica Scandinavica.
[94] J. O'Connor,et al. Accelerated fracture healing in mice lacking the 5-lipoxygenase gene , 2010, Acta orthopaedica.
[95] Li Sun,et al. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation , 2006, Proceedings of the National Academy of Sciences.
[96] J. Capo,et al. A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing , 2009, Acta orthopaedica.
[97] M. Endres,et al. Immunomodulation of tissue-engineered transplants: in vivo bone generation from methylprednisolone-stimulated chondrocytes , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.
[98] U. Ritz,et al. Cell viability, osteoblast differentiation, and gene expression are altered in human osteoblasts from hypertrophic fracture non-unions. , 2008, Bone.
[99] J. Magaziner,et al. Persistent changes in interleukin-6 and lower extremity function following hip fracture. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[100] G. Duda,et al. The early fracture hematoma and its potential role in fracture healing. , 2010, Tissue engineering. Part B, Reviews.
[101] H. Pieringer,et al. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment? , 2007, Seminars in arthritis and rheumatism.
[102] T. Wirth,et al. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. , 2009, Bone.